Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): A prospective German registry in stage IV NSCLC AIO-TRK-0315.

Griesinger, F., Eberhardt, W.E., Marschner, N., Jänicke, M., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Sebastian, M., Thomas, M., 2016.

J Clin Oncol 34 (suppl; abstr TPS9108). doi: 10.1200/JCO.2016.34.15_suppl.TPS9108

Studie: CRISP; Indikation: Bronchialkarzinom; Jahr: 2016; Veranstaltung: ASCO; Journal: Journal of Clinical Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com